NAMSW NewAmsterdam Pharma Company N.V.

Fundamentals / CIK 0001936258 / USD
Other share classes on CIK 0001936258: NAMS

NewAmsterdam Pharma Company N.V. reported $25.94M in revenue and a net loss of $204.9M for the trailing twelve months ended September 30, 2026 (up 5406.9% year over year), with a -900.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NAMSW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$126.7M$63.36M$0-$234.6MFY 2021 Net Income: -$41.78M2021FY 2022 Revenue: $102.7MFY 2022 Net Income: -$22.63M2022FY 2023 Revenue: $14.09MFY 2023 Net Income: -$176.9M2023FY 2024 Revenue: $45.56MFY 2024 Net Income: -$241.6M2024FY 2025 Revenue: $22.50MFY 2025 Net Income: -$203.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $22.50M $45.56M $14.09M $102.7M --
Research & Development $141.8M $151.4M $159.4M $86.74M $28.97M
Selling, General & Admin $106.4M $70.45M $37.63M $19.51M $6.00M
Total Operating Expenses $248.2M $221.9M $197.1M $106.3M $34.98M
Operating Income -$225.7M -$176.3M -$183.0M -$3.56M -$34.98M
EBITDA -$225.5M -$176.2M -$182.9M -$3.55M -$34.97M
Interest Income $27.59M $16.88M $11.28M -- --
Interest Expense -- -- -- $287K $411K
Income Before Tax -$203.8M -$241.6M -$176.9M -$22.63M -$41.78M
Income Tax Expense -- -$1.0K $27K -- --
Net Income -$203.8M -$241.6M -$176.9M -$22.63M -$41.78M
Basic EPS -$1.72 -$2.56 -$2.15 -$1.19 -$3.81
Diluted EPS -$1.72 -$2.56 -$2.15 -$1.19 -$3.81
Basic Shares Outstanding 118.4M 94.4M 82.2M 19.0M 11.0M
Diluted Shares Outstanding 118.4M 94.4M 82.2M 19.0M 11.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $19.16M $3.70M $3.04M $32K $348K $19.14M $2.98M $12.77M
Research & Development $39.36M $41.67M $38.01M $38.59M $30.97M $27.52M $44.75M $34.90M
Selling, General & Admin $24.00M $26.89M $23.45M $27.42M $24.52M $27.26M $27.15M $21.11M
Total Operating Expenses $63.35M $68.56M $61.46M $66.01M $55.49M $54.78M $71.90M $56.00M
Operating Income -$44.19M -$64.86M -$58.42M -$65.98M -$55.14M -$35.63M -$68.92M -$43.23M
EBITDA -$44.12M -$64.81M -$58.36M -$65.92M -$55.08M -$35.59M -$68.87M -$43.18M
Interest Income $5.19M $5.81M $5.65M $6.47M $6.71M $7.05M $7.35M $4.49M
Income Before Tax -$16.18M -$64.14M -$48.44M -$74.92M -$72.00M -$17.36M -$39.53M -$92.18M
Income Tax Expense $1.21M -- -- -- -- -- -- --
Net Income -$17.39M -$64.14M -$48.44M -$74.92M -$72.00M -$17.36M -$39.53M -$92.18M
Basic EPS -$0.14 -$0.52 -$0.40 -- -$0.61 -$0.15 -$0.34 --
Diluted EPS -$0.14 -$0.52 -$0.40 -- -$0.61 -$0.15 -$0.34 --
Basic Shares Outstanding 124.1M 123.4M 121.7M -- 119.0M 118.6M 116.1M --
Diluted Shares Outstanding 124.1M 123.4M 121.7M -- 119.0M 118.6M 116.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $490.0M $771.7M $340.4M $467.7M
Short-Term Investments $146.2M $62.45M -- --
Cash & Short-Term Investments $636.2M $834.2M $340.4M $467.7M
Total Current Assets $675.7M $863.4M $346.8M $478.0M
Property, Plant & Equipment, Net $383K $242K $46K $34K
Long-Term Investments $92.61M -- -- --
Total Non-Current Assets $93.58M $1.21M $306K $518K
Total Assets $769.3M $864.6M $347.1M $478.5M
Accounts Payable $8.97M $4.74M $16.92M $11.85M
Deferred Revenue (Current) $3.99M $6.01M $8.94M $13.87M
Total Current Liabilities $85.79M $106.9M $49.90M $36.06M
Deferred Revenue (Non-Current) -- -- $1.02M $4.79M
Total Non-Current Liabilities $66K $202K $8.81M $12.37M
Total Liabilities $85.85M $107.1M $58.70M $48.43M
Total Debt (incl. Leases) $202K $448K $60K $126K
Common Stock $14.28M $13.44M $10.17M $10.05M
Retained Earnings -$762.4M -$558.6M -$317.0M -$140.0M
Accumulated Other Comp. Income $4.79M $4.47M $4.42M $4.42M
Total Stockholders' Equity $683.4M $757.5M $288.4M $430.1M
Total Equity $683.4M $757.5M $288.4M $430.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $423.1M $424.2M $457.6M $490.0M $538.4M $563.9M $748.4M $771.7M
Short-Term Investments $205.1M $209.7M $178.5M $146.2M $164.5M $175.3M $60.06M $62.45M
Cash & Short-Term Investments $628.2M $633.9M $636.1M $636.2M $702.9M $739.2M $808.5M $834.2M
Total Current Assets $672.2M $659.2M $658.0M $675.7M $732.3M $769.9M $817.3M $863.4M
Property, Plant & Equipment, Net $554K $411K $379K $383K $323K $312K $238K $242K
Long-Term Investments $14.88M $44.41M $71.24M $92.61M $53.09M $44.17M -- --
Total Non-Current Assets $15.82M $45.24M $74.60M $93.58M $54.10M $45.26M $1.11M $1.21M
Total Assets $688.0M $704.5M $732.6M $769.3M $786.4M $815.1M $818.4M $864.6M
Accounts Payable $4.63M $5.42M $8.09M $8.97M $3.63M $5.89M $6.09M $4.74M
Deferred Revenue (Current) $5.71M $2.80M $3.99M $3.99M -- -- $3.03M $6.01M
Total Current Liabilities $57.15M $72.97M $67.42M $85.79M $58.27M $36.51M $40.91M $106.9M
Total Non-Current Liabilities $49K $56K $0 $66K $85K $103K $137K $202K
Total Liabilities $57.20M $73.03M $67.42M $85.85M $58.36M $36.62M $41.05M $107.1M
Total Debt (incl. Leases) $76K $82K $23K $202K $266K $328K $389K $448K
Common Stock $15.03M $14.73M $14.59M $14.28M $14.11M $14.01M $13.97M $13.44M
Retained Earnings -$892.4M -$875.0M -$810.8M -$762.4M -$687.5M -$615.5M -$598.1M -$558.6M
Accumulated Other Comp. Income $3.62M $3.86M $4.22M $4.79M $4.64M $4.33M $4.43M $4.47M
Total Stockholders' Equity $630.8M $631.4M $665.2M $683.4M $728.1M $778.5M $777.4M $757.5M
Total Equity $630.8M $631.4M $665.2M $683.4M $728.1M $778.5M $777.4M $757.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$203.8M -$241.6M -$176.9M -$22.63M -$41.78M
Depreciation & Amortization $220K $113K $49K $9.0K $5.0K
Stock-Based Compensation $59.42M $33.62M $24.57M $4.12M $1.24M
Change in Payables $4.91M -$12.95M $5.07M $4.81M $6.56M
Operating Cash Flow -$147.8M -$158.6M -$141.2M $10.66M -$29.51M
Capital Expenditure -$246K -$672K -$24K -$221K -$24K
Free Cash Flow -$148.0M -$159.2M -$141.2M $10.44M -$29.54M
Purchases of Investments -$296.7M -$62.18M -- -- --
Investing Cash Flow -$174.9M -$62.85M -$24K -$221K -$24K
Financing Cash Flow $29.52M $659.5M $8.91M $391.9M $84.70M
Net Change in Cash -$293.2M $438.1M -$132.3M $402.3M $55.17M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$17.39M -$64.14M -$48.44M -$74.92M -$72.00M -$17.36M -$39.53M -$92.18M
Depreciation & Amortization $67K $59K $62K $59K $64K $45K $52K $51K
Stock-Based Compensation $12.52M $18.38M $18.00M $14.02M $15.01M $15.18M $15.21M $9.41M
Change in Payables -$835K -$2.69M -$793K $5.32M -$2.27M -$391K $2.25M -$3.20M
Operating Cash Flow -$39.77M -$39.21M -$30.60M -$40.88M -$32.77M -$37.67M -$36.47M -$37.48M
Capital Expenditure -$177K -$80K -$38K -$100K -$42K -$88K -$16K -$3.0K
Free Cash Flow -$39.95M -$39.29M -$30.64M -$40.98M -$32.81M -$37.76M -$36.48M -$37.48M
Purchases of Investments -$13.01M -$51.18M -$62.47M -$71.54M -$31.85M -$183.7M -$9.63M --
Investing Cash Flow $33.70M -$4.76M -$11.51M -$21.14M $2.51M -$159.1M $2.85M -$62.18M
Financing Cash Flow $5.45M $11.04M $11.06M $13.68M $5.89M $3.42M $6.52M $456.6M
Net Change in Cash -$623K -$32.94M -$31.05M -$48.33M -$24.37M -$193.4M -$27.09M $357.0M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1002.9% -386.9% -1298.6% -3.5% --
Net Profit Margin -905.7% -530.3% -1255.8% -22.0% --
Return on Equity (ROE) -29.8% -31.9% -61.4% -5.3% --
Return on Assets (ROA) -26.5% -27.9% -51.0% -4.7% --
Current Ratio 7.88x 8.08x 6.95x 13.26x --
Quick Ratio 7.42x 7.80x 6.82x 12.97x --
Debt to Equity 0.00x 0.00x 0.00x 0.00x --
Revenue Growth (YoY) -50.6% +223.4% -86.3% -- --
Operating Cash Flow Growth (YoY) -- -- -1424.1% -- --
Free Cash Flow Growth (YoY) -- -- -1452.4% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -900.1% -3432.2% -953.6% -1002.9% -575.8% -270.0% -402.5% -386.9%
Net Profit Margin -789.9% -3644.2% -942.8% -905.7% -627.3% -258.9% -397.5% -530.3%
Return on Equity (ROE) -32.5% -41.1% -32.0% -29.8% -30.4% -21.3% -24.1% -31.9%
Return on Assets (ROA) -29.8% -36.8% -29.0% -26.5% -28.1% -20.3% -22.9% -27.9%
Current Ratio 11.76x 9.03x 9.76x 7.88x 12.57x 21.08x 19.98x 8.08x
Quick Ratio 10.99x 8.69x 9.43x 7.42x 12.06x 20.24x 19.76x 7.80x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) +5406.9% -80.7% +2.1% -99.7% -98.8% +740.1% +112.6% +1490.5%
Source: SEC EDGAR CompanyFacts (CIK 0001936258) · from December 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal